HLA-DPB1 glutamate 69: a genetic marker of beryllium disease
L Richeldi, R Sorrentino, C Saltini - Science, 1993 - science.org
Chronic beryllium disease (CBD) is a lung disorder related to beryllium exposure and is
characterized by the accumulation in the lung of beryllium-specific CD4+ major …
characterized by the accumulation in the lung of beryllium-specific CD4+ major …
A Structural Framework for Deciphering the Link Between IAg7 and Autoimmune Diabetes
AL Corper, T Stratmann, V Apostolopoulos, CA Scott… - Science, 2000 - science.org
Susceptibility to murine and human insulin-dependent diabetes mellitus correlates strongly
with major histocompatibility complex (MHC) class II IA or HLA-DQ alleles that lack an …
with major histocompatibility complex (MHC) class II IA or HLA-DQ alleles that lack an …
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor
MT De Magistris, J Alexander, M Coggeshall, A Altman… - Cell, 1992 - cell.com
A novel mechanism for inhibition of T cell responses is described. Using the recognition of
the influenza hemagglutinin(HA) 307-319 peptide in the context of DFll class II major …
the influenza hemagglutinin(HA) 307-319 peptide in the context of DFll class II major …
Copolymer 1 acts against the immunodominant epitope 82–100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex …
R Aharoni, D Teitelbaum, R Arnon… - Proceedings of the …, 1999 - National Acad Sciences
The synthetic random amino acid copolymer Copolymer 1 (Cop 1, Copaxone, glatiramer
acetate) suppresses experimental autoimmune encephalomyelitis, slows the progression of …
acetate) suppresses experimental autoimmune encephalomyelitis, slows the progression of …
The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder
T Stratmann, V Apostolopoulos… - The Journal of …, 2000 - journals.aai.org
Susceptibility to insulin-dependent diabetes mellitus is linked to MHC class II genes. The
only MHC class II molecule expressed by nonobese diabetic (NOD) mice, IA g7, shares a …
only MHC class II molecule expressed by nonobese diabetic (NOD) mice, IA g7, shares a …
Genetic factors in the etiology and pathogenesis of autoimmunity1
DA Carson - The FASEB journal, 1992 - Wiley Online Library
Family and population studies indicate that several different genes can increase
susceptibility to autoimmune diseases. Established genetic risk factors include genes …
susceptibility to autoimmune diseases. Established genetic risk factors include genes …
A Peptide-binding Motif for IAg7, the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice
LC Harrison, MC Honeyman, S Trembleau… - The Journal of …, 1997 - rupress.org
The class II major histocompatibility complex molecule I-Ag7 is strongly linked to the
development of spontaneous insulin-dependent diabetes mellitus (IDDM) in non obese …
development of spontaneous insulin-dependent diabetes mellitus (IDDM) in non obese …
A new anti-rheumatic drug, T-614, effectively suppresses the development of autoimmune encephalomyelitis
Y Aikawa, N Tanuma, T Shin, S Makino… - Journal of …, 1998 - Elsevier
In the present study, we examined the therapeutic effects of T-614 (3-formylamino-7-
methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one), a new anti-rheumatic drug, on a …
methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one), a new anti-rheumatic drug, on a …
Identification of a pathogenic epitope involved in initiation of Heymann nephritis.
D Kerjaschki, R Ullrich, K Diem… - Proceedings of the …, 1992 - National Acad Sciences
Heymann nephritis is an experimental autoimmune disease model for human membranous
nephropathy. We have recently identified a pathogenic epitope, clone 14 (C14), responsible …
nephropathy. We have recently identified a pathogenic epitope, clone 14 (C14), responsible …
The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus
A Muir, DA Schatz, NK Maclaren - … and metabolism clinics of North America, 1992 - Elsevier
The past decade has seen great advances in our understanding of the pathogenesis of
IDDM. This knowledge has led to investigative use of a battery of immunologic, genetic, and …
IDDM. This knowledge has led to investigative use of a battery of immunologic, genetic, and …